Wednesday, 29 April 2020

Hemophilia A Treatment Market Future Technological Trends and Business Opportunities By 2026

Hemophilia A patients have begun to shift from short acting to EHL factors and from on demand therapies to prophylactics. The increasing prevalent population of Hemophilia A and the rise in demand of the prophylactics treatments in developed markets will have a great impact on this market.

According to the US Centers for Disease Control and Prevention, hemophilia A occurs in 1 in 5,000 live male births. Hemophilia A is about four times as common as hemophilia B.  The number of people with hemophilia in the United States is estimated to be about 20,000 individuals. Approximately 75% of people with hemophilia around the world still receive inadequate treatment or have no access to treatment.


As of January 2018, there are over 450 reported Clinical Trials for Hemophilia A with 50+ trials currently actively ongoing. Out of all the trials, 120+ studies are funded by the pharmaceutical companies alone. The major players with drugs in Phase III are Alnylam Pharmaceuticals, Sanofi (Genzyme), BioMarin Pharmaceutical, Hoffmann-La Roche, Sinocelltech Ltd., Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd, Octapharma, LFB USA, Inc., Novo Nordisk A/S, Pfizer and others.

Polaris Market Research expects that with the expected launch of the promising treatments, the market is expected to expand in Hemophilia A segment. The United States dominates the Hemophilia A treatment market followed by Europe 5 and Japan. The prophylaxis segments are predicted to be the fastest growing segment whereas the on-demand therapy segment is expected to contribute close to ~50% to the market during the forecast period. With the increase in the R&D investments and rising drug innovations in this field, the market is expected to significantly expand in the next five years.

Have Questions? Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/hemophilia-a-treatment-market/inquire-before-buying

RNA based therapeutics and curative gene therapies are rapidly progressing through clinical development and are seen as an attractive segment of this market.

Polaris Market Research has provided the forecasts of the Global Hemophilia A Market from 2016-2022. The major segments which has been investigated in the global market from 2016-2022 are:

  • Market Analysis by Hemophilia A treatment
  • Market Analysis by Treatments/Marketed Drugs
  • Market Analysis by G7 countries


The Marketed Therapies undertaken in forecast from 2016-2022 are:
  • Afstyla Sales Forecast-2016-2022
  • Eloctate Sales Forecast-2016-2022
  • Hemlibra Sales Forecast-2016-2022
  • Kogenate FS Sales Forecast-2016-2022
  • Kovaltry Sales Forecast-2016-2022
  • Nuwiq Sales Forecast-2016-2022
  • Obizur Sales Forecast-2016-2022


The Major Indications in Hemophilia A Therapy area:
  • Prophylaxis-Market Forecast 2016-2022
  • On-demand therapy-Market Forecast 2016-2022
  • Inhibitor therapy- Market Forecast 2016-2022


The Market Forecast of Hemophilia A Treatment by G7 Countries (2016-2022)
  • United States- Market Forecast (2016-2022)
  • Germany- Market Forecast (2016-2022)
  • France-Market Forecast (2016-2022)
  • Italy- Market Forecast (2016-2022)
  • Spain- Market Forecast (2016-2022)
  • United Kingdom- Market Forecast (2016-2022)
  • Japan- Market Forecast (2016-2022)


Leading Companies investigated in the Report are
  • CSL Behring
  • Shire
  • Bayer
  • Biogen
  • Genentech
  • Bioverativ
  • Alnylam Pharmaceuticals
  • Sanofi (Genzyme)
  • BioMarin Pharmaceutical
  • Hoffmann-La Roche
  • Sinocelltech Ltd.
  • Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
  • Octapharma
  • LFB USA, Inc.
  • Novo Nordisk A/S
  • Pfizer


Contact us-
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com

on No comments:
Labels: , ,

Eubiotics Market Outlook | Development Factors, Latest Opportunities and Forecast 2026

The global eubiotics market is expected to reach more than USD 8.60 billion by 2026 with a CAGR of 5.6% during the forecast period as per a new study released by Polaris Market Research. The report “Eubiotics Market [By Ingredient Type (Prebiotics, Probiotics, Organic Acids, Essential Oil); By Functionality (Yield, Productivity, Immunity, Nutrition & Gut Health); By Application (Poultry, Cattle, Aquaculture, Swine); By Regions]: Market size & Forecast, 2017 – 2026”. provides an extensive analysis of present market dynamics and predicted future trends.

Now-a-days there are many stringent regulations on the usage of antibiotic growth promoters. There has also been a pressure from consumer towards food safety, these two are the main drivers to drive the growth of eubiotics.



The specific organic acid such as essential oil compounds, benzoic acid, probiotics and nucleotides can be used as a single product or can be combined with two or more eubiotics to achieve quality result. Prebiotics can be defined as a specific kind of micro-organism that helps to improve the balance of pathogenic to beneficial bacteria. Prebiotics comes under non-digestible oligosaccharides that serves subtract for probiotics and helps to compete with pathogens which helps to regulate` the gut cell adhesion.

Eubiotics are used for weaning piglets at the time of transition from suckling milk to feeding solid feed. This also helps in preventing bacteria growth and helps to improve digestion of feed ingredients. It is also used in the form of benzoic acid as preservatives. The usage in the food industry has also fueled the growth of eubiotics market.

There are many projects undertaken at the Pig Research Centre of the Danish Agriculture and Food Council on eubiotics. There are numerous tests taken to find the performance of eubiotics on animals. One project was undertaken where it was found that supplementation of 0.5% of benzoic acid is similar to the effect of the usage of1% benzoic acid. Piperin, an essential oil compound helps to stimulate the production of digestive enzymes. The above characteristics have led to the increase in the demand for eubiotics.

Have Questions? Inquiry before buying this report by clicking the link below: 
 https://www.polarismarketresearch.com/industry-analysis/eubiotics-market/inquire-before-buying

Key Findings from the study suggest that the largest share of the eubiotics market in 2017 was of the Europe region. Europe was the first region to put a ban on use of antibiotics as growth promoters. Increasing concerns of animal safety and nutrition that eventually lead to components of processed meat for humans are the major concerns for the region’s ban on antibiotics. This ban created remarkable opportunities for the eubiotics which are the direct substitutes.   

The top key players in Eubiuotics market are Cargill, BASF SE,DSM N.V., Koninklijke, Kemin Industries, Novozymes, Addcon, Novus International Inc, Lallemand Inc, Chr. Hansen Holding A/S

Contact us-
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com

on No comments:
Labels: , , ,

eClinical solutions Market Deep Company Profiling of Leading Players 2020-2026

the global eClinical solutions market is anticipated to reach over USD 12,985 million by 2026. According to a new study published by Polaris Market Research, In 2017, the CTMS segment dominated the global market, in terms of revenue. In 2017, North America accounted for the majority share in the global eClinical solutions market.
The key players profiled in the report are Oracle Corporation, Parexel International Corporation, Medidata Solution, Inc., DataTrak International, Inc., CRF Health, OmniComm Systems, BioClinica Inc., eResearch Technology, eClinical Solutions, Inc., and PHT Corporation. The prominent players operating in the industry have adopted various strategies such as mergers and acquisition, product innovation and expansion, and R&D of innovative products.

Government organizations across the globe have implemented stringent guidelines to obtain error-free authentic clinical data due to the burgeoning number of clinical data research. EClinical data software facilitates processing of real-time data entries. Moreover, the need to process massive amount of data in the least possible time increases the adoption of these solutions.

The governments of various countries across the globe have sanctioned funds to promote clinical research of novels drugs. Increase in incidence of diseases across the globe has enforced government agencies to expedite the process of drug approval. The adoption of clinical data management systems has increased in the recent years to process the queueing molecules in the development phase of clinical research.

Technological advancements in eClinical software such as use of cloud computing to secure the data and improve accessibility across remote locations are expected to boost the market growth. Cloud based solution software dominated the global market in 2017, owing to the ease of delivery and convenience of upgrading to advanced versions. This segment has been gaining traction in the recent years, and is expected to grow at the fastest rate during the forecast period.

Several pharmaceutical organizations have deployed eClinical solution software to comply with the norms of the regulatory bodies for processing clinical data without errors and without any scope for manipulation. According to the ALCOA standard, the use of electronic clinical outcome assessments (eCOA) is essential in clinical trials, as these use smartphones, tablets, and personal computers to allow patients, clinicians, and their caregivers to directly report outcomes, which ensure highly productive data for better understanding of patient experience and faster approval process.
Among end users, the CROs segment is expected to grow at the fastest rate due to the ongoing trend of outsourcing clinical research operations to these third party organizations to save time and cost. As most of the drugs that have cleared Phase III clinical trials can be marketed under FDA norms with proper recommendations and guidelines through a new drug application (NDA), a majority of the drugs across the globe are in this phase of clinical research. Hence, most of the clinical data management systems were used for conducting phase III clinical trials.
Contact us-
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
on No comments:
Labels: , , ,

Blood Testing Market Historical Growth, Regional Trends, Forecast 2026

According to a new study published by Polaris Market Research the worldwide blood testing market is anticipated to reach USD 65,464.3 million by 2026. In 2017, the glucose testing segment dominated the global market, in terms of revenue, whereas geographically, North America accounted for the majority share in the global blood testing market.

Increasing dependency of doctors on blood-based diagnosis to ensure reliable and rapid treatment, along with rapidly growing geriatric population are the major factors which drives the blood testing device market. Moreover, surge in the demand for blood donations and organ donors, and increasing awareness about the safety of donated blood further increase the market growth. The other key factors enhancing the global market growth include multiplying prevalence of infectious diseases such as bacterial and viral diseases and other health-related disorders such as HIV, cancer, thyroid, and genetic disorders, and the exponential increase in the number of point of care (POC) testing. Use of self-testing products and home diagnostic tests, blood testing in under-developed countries, and research and development for developing new testing technologies further provide growth opportunities for the blood testing market in the forecast period.


In the era of rapid and effective medical treatments, physicians and other medical personnel are dependent on various types of laboratory testing in order to make an accurate diagnosis and carry out subsequent treatment measures. Thus, increasing reliance on physicians for blood-based diagnosis to ensure reliable and rapid treatment procedures are the factors anticipated to enhance the blood testing market in the forecast period. Generally, the elderly population who are susceptible to age-related diseases such as diabetes and cardiovascular diseases require more frequent blood testing. Furthermore, the elderly population undergoes complex surgical procedures such as dialysis, joint replacements and cancer therapies which requires blood transfusions. These factors are anticipated to bolster the demand for blood testing in the upcoming years.
  
Recent times have witnessed an increase in the prevalence of infectious diseases such as bacterial and viral diseases, and other disorders such as HIV, cancer, thyroid, and genetic disorders in all age groups and population. Blood testing plays a vital role in the identification of the causative agents of these diseases and disorders thereby boosting the growth of this market.  Also, the growing number of POC testing has led to the increased growth of the market.



Asia Pacific is anticipated to grow at the highest CAGR during the forecast period owing to the increasing economic growth in developing economies such as India, China and Japan. Various factors governing the growth in this region include large patient pool, increasing ageing population, rising standard of living, high disposable income, increasing health awareness, and improving medical facilities. Furthermore, global players are tapping into these countries, which in turn are expected to boost the market growth.

The different types of blood testing include glucose testing, lipid profile, liver function tests, prostate specific antigen, hormones, blood urea nitrogen, high-sensitivity c-reactive protein, thyroid stimulating hormone, serum nicotine/cotinine and others. The glucose testing segment is expected to dominate the market during the forecast period due to increasing population of diabetic patients and changing lifestyles. Blood glucose testing is conducted by both laboratories and point of care testing.

The major market players profiled in the report include Abbott Laboratories, Alere, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Beckman Coulter, bioMérieux SA, Biomerica Inc., Bruker Corporation, Nanosphere Inc., Nipro Diagnostics, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific Inc. and Trinity Biotech PLC among others. These market players have adopted various strategies such as merger & acquisitions, novel product development, and venture capital investments among others to expand their foothold and increase their customer base.


Contact us

Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , , ,

Agriculture Drones Market Manufacturers, Regions, Type and Application, Forecast to 2026

According to a new report published by Polaris Market Research, the worldwide agriculture drones market is anticipated to reach around USD 8,019.8 million by 2026. In 2017, the field mapping segment dominated the global market, in terms of revenue. North America is expected to be the leading contributor to the global market in 2017.

There has been an increasing adoption of agricultural drones across the world owing to growing agricultural industry, and high-demand for high quality food crops. The growing use of drones for crop health monitoring, weed detection, variable rate application, crop scouting, and livestock management supports the agriculture drones market growth. The growing population and increasing automation of farm operations further supports agriculture drones market growth. The global agricultural drones market is driven by the increasing need to improve the quality of crops produced, maximize crop production, and enhance productivity. Other factors driving the growth of this market include growth in the global agricultural industry, reducing availability of labors, and increasing labor costs. However, safety, security, and privacy concerns restrict the growth of the agricultural drones market. Growing demand from emerging economies, and technological advancements are factors expected to provide numerous growth opportunities in the coming years.


According to the United States Department of Agriculture, National Agriculture Imagery Program (NAIP) utilizes drones with camera and sensor payloads to develop digital orthophotographs. These images are available to the government agencies and general public for estimation of land usage, crop plantings and yields, and others. In March 2016, Agribotix LLC partnered with Inter-American Institute for Cooperation on Agriculture (IICA) to introduce agriculture drone and data analytics for crop health management and improvement of agriculture production.


North America generated the highest revenue in the market in 2017. The increasing population, and growing demand for high quality crops drives the growth of this market. Growing cost of labor and increasing automation in agricultural practices further support global agriculture drones market growth. Increasing investments and subsidies in the agriculture sector by governments are expected to boost the adoption of drones for increased productivity in farms.


The different components used in agriculture drones include hardware, software, and services. In 2017, the hardware segment accounted for the largest share in the global market. The hardware used in agricultural drones include technologically advanced cameras, navigation systems, frames, controllers, propulsion systems, and others. The hardware components are required for capturing information and monitoring of fields and crops.

The well-known companies profiled in the report include Trimble Navigation Limited, DJI Technology Co., Ltd, Parrot SA, Drone Deploy, Agribotix LLC, Honeycomb Corporation, Aerovironment, Inc., Eagle UAV Services LLC, 3D Robotics Inc., AgEagle Aerial Systems, Inc., Autocopter Corp, and Ursula Agriculture. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

Contact us

Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , , ,

Friday, 24 April 2020

Apheresis Equipment Market Growth Opportunities to Tap into in 2020-2026

The global apheresis equipment market is anticipated to reach over USD 5,351.17 Million by 2026 according to a new research published by Polaris Market Research

An apheresis apparatus is a device which collects blood that is detached from a donor’s or patient’s body and splits up it into its several constituents such as red blood cells, platelets, plasma, and white blood cells. Depending on the purpose for apheresis, one of these constituents is collected and isolated by the equipment, while the others components are reverted to the body.

Polaris Market Research’s report on apheresis equipment market spans more than 90 pages and includes more than 70 tables and figures. Browse the detailed table of contents for, “By Procedure Type (Plasmapheresis, Plateletpheresis, Leukapheresis, Lymphopheresis, Erythrocytapheresis); By Application (Blood Donation, Therapeutic Purpose); By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Blood Donation Centers); By Regions (North America – U.S., Canada; Europe – Germany, UK, France, Italy, Russia; Asia-Pacific – China, India, Japan, Australia; Latin America – Brazil, Mexico; Middle East & Africa – UAE, Saudi Arabia, South Africa)]: Market size & Forecast, 2017 – 2026” on 


Some major key players in global apheresis equipment market include Haemonetics Corporation, Fresenius Kabi (Fenwal), Asahi Kasei Kuraray Medical Co. Ltd., Terumo BCT, Inc., HemaCare Corporation, Therakos, Inc. and B. Braun Melsungen AG among others.

Rising occurrence of blood-related ailments leading to the increase in demand for plasma and platelets is expected to serve the market as a high influence rendering driver. Moreover, the apheresis equipment market is driven by advancement in technology intended at delivering comparatively more rapid and effective results. Healthcare experts and researchers are now in the need for instruments that require minimum human involvement and institution of fully automatic apheresis equipment with improved displays is anticipated to augment the usage rates further bolstering the market growth.

The global apheresis equipment market is segmented on the basis of procedure type, application, end user, and geography. On the basis of procedure type, the global Apheresis Equipment Market is segmented into Plasmapheresis, Plateletpheresis, Leukapheresis, Lymphopheresis, and Erythrocytapheresis. In 2017, the Plasmapheresis is estimated to dominate the market growth. Increasing occurrence of blood-related diseases and rising demand for plasma-derived drugs are anticipated to serve as a primary growth driver of this segment. On the basis of application, the global apheresis equipment market is segmented into Blood Donation and Therapeutic Purpose. The therapeutic purpose is further categorized into Renal, Hematology, and Other Rare Diseases. On the basis of the end user, the global apheresis equipment market is segmented into hospitals, clinics, ambulatory surgical centers, and blood donation centers. On the basis of end users, the hospital segment is anticipated to dominate the market growth in 2017.


On the basis of region, the global apheresis equipment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was projected to dominate the global apheresis equipment market. The domination is majorly owing to growing healthcare spending, the existence of a high number of market players, high donor awareness levels, and relatively higher number of Research & Development movements concerning to product manufacturing and marketing accomplishments in this region. However, Asia Pacific is expected to dominate the global apheresis equipment market. Growing amount of diverse types hematological ailments in this region is the major factor boosting the growth of apheresis equipment market during the forecast period.


Contact us
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , , ,

Transcatheter Aortic Valve Replacement Market Report is best solution to Growing Economical Trend by 2020-2025

The global transcatheter aortic valve replacement (TAVR) market is anticipated to reach USD 8,241.4 Million by 2025 according to a new study published by Polaris Market Research.

Transcatheter aortic valve replacement (TAVR), known as transcatheter aortic valve implantation (TAVI) the surgical procedure for heart disease wherein transcatheter heart valve is used to replace the damaged as well as old heart valve. Transcatheter heart valve implantation is a minimally invasive process that helps in substituting the damaged heart valve with a prosthetic valve for treatment of mitral regurgitation and unembellished aortic stenosis. Transcatheter aortic valve replacement procedure that helps to diminish severe degenerative aortic stenosis and increases the survival rate of patients.



The global Transcatheter Aortic Valve Replacement (TAVR) Market is driven by factors such as growing number of the patient pool with cardiovascular ailments such as coronary artery diseases, heart failures, and hypertension. According to World Health Organization (WHO), the number of people suffering cardiovascular disorders will surge to 22.2 million by 2030 globally. Moreover, rising implementation of minimally intrusive processes over traditional surgical open-heart procedures, reduction in hospital stays, low risk of infection, minimal blood loss is further propelling the market. Moreover, increase in occurrence of aortic stenosis disorders coupled with rise in elderly population, evolution in implementation rate of transcatheter aortic valve implantation procedure owing to high demand for minimally invasive procedures, an increase in medical and clinical indication of safety & efficacy and new products approvals are other factors propelling the global Transcatheter Aortic Valve Replacement (TAVR) Market growth.
  
The global transcatheter valve replacement (TAVR) market is segmented on the basis of surgical procedure, end user, and geography. On the basis of surgical procedure, the global transcatheter valve replacement (TAVR) market is categorized into Transfemoral (TF) Implantation, Transapical (TA) Implantation, and Transaortic Implantation. The global market by the surgical procedure is dominated by Transfemoral (TF) Implantation majorly due to growing focus on tentative products by key players which are estimated to boost the market growth of transcatheter valve replacement (TAVR) market globally. Moreover, Transfemoral implantation is the standardized as well as consistent TAVR procedure, in which an artificial valve is inserted through the femoral blood vessel with the minimally invasive procedure and negligible anesthesia. Thus, the transferomal (TF) implantation segment accounted for the highest market share in 2017 and is anticipated to preserve the governance during the forecast period.


Based on the end users, the global transcatheter aortic valve replacement (TAVR) market is further categorized into hospitals, ambulatory surgical centers, and cardiac catheterization laboratory. The Hospital segment is expected to show the highest market growth over the forecast period. Growing patient pool and rising demand for efficient and effective surgical process with shorter recovery time and reduced hospital stay are the key factors driving the market shares for hospitals in global transcatheter aortic valve replacement (TAVR) market.

Some of the major key players operating in global Transcatheter Aortic Valve Replacement (TAVR) Market are Boston Scientific Corporation, Direct Flow medical, Inc., Edwards Lifesciences Corporation, HLT, Inc., JenaValve Technology, Inc., Medtronic plc, Meril Life Sciences Pvt. Ltd., St. Jude Medical, Inc., SYMETIS SA, and Transcatheter Technologies GmbH among others.


Contact us
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com


on No comments:
Labels: , ,

Sepsis Diagnostics Market is anticipated to reach over USD 1033.02 Million by 2026

Sepsis diagnostics market is anticipated to reach over USD 1033.02 Million by 2026 according to a new study published by Polaris Market Research.

Sepsis is a type of fatal organ dysfunction ailment rises when the body responses to an infection to its own organs and tissues and organs. This disorder can be triggered due to the weakened immune system, kidney or liver disease, chronic illness such as cancer, and severe wounds. Sepsis can be of two types septic shock in which there are the indications of severe sepsis including a low blood pressure and another is severe sepsis when there’s organ failure.


The high occurrence of people suffering sepsis and the demand for appropriate diagnosis and treatment is anticipated to bolster the demand for the sepsis diagnostics market. In addition, rising number of hospital-acquired infections (HIA) are expected to support the growth of the market during the forecast period. Hospital-acquired infections primarily include surgical site and urinary tract infections, which result in sepsis. According to the World Health Organizations (WHO), 7 out of every 100 hospitalized patients develop hospital-acquired infections in developed economies. This, in turn, demands proper diagnosis, further bolstering the market growth. On the other hand, pneumonia is also a significant driving factor for the high demand of sepsis diagnostics market as it is one of the major causes of septic shock.
  
The global Sepsis Diagnostics Market is segmented on the basis of products, technology, pathogen, testing type, and geography. On the basis of products, the global Sepsis Diagnostics Market is segmented into Instruments, Blood Culture Media, and Assay Kits and Reagents. In 2017, the blood culture media was projected to be the major market sharing segment during the forecast period. The cost-effectiveness mode of the test is the primary reason for the major market share. In addition, due to the lower cost, the blood culture method is also considered as the gold standard method. On the basis of technology, the global sepsis diagnostics market is segmented into Microbiology, Molecular Diagnostics, Immunoassays, and Flow Cytometry. 




The microbiology segment was estimated to be the dominating segment due to the fact that it permits the identification and quantitative detection of microbes for sepsis diagnosis through the application of culture media tests. On the basis of the pathogen, the global sepsis diagnostics market is segmented into Bacterial Sepsis and Fungal Sepsis. The bacterial sepsis id further categorized into, gram-positive bacteria and gram-negative bacteria. In 2017, the bacterial sepsis segment is anticipated to dominate the segment. This is due to the patients suffering from the blood poisoning disease is a generally considered as a casualty of bacterial infection. On the basis of test type, the global sepsis diagnostics market is segmented into Laboratory Testing and PoC Testing. In 2017, the laboratory testing type is estimated to dominate the market.

Some major key players in global Sepsis Diagnostics Market include Becton, Dickinson and Company, bioMérieux SA, Roche Diagnostics, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Cepheid Inc., Bruker Corporation, and Nanosphere, Inc. among others.


Contact us
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com




on No comments:
Labels: , ,

Constrained Layer Damping Market Historical Growth, Regional Trends, Forecast 2026

The global Constrained Layer Damping (CLD) market is anticipated to reach USD 1,160 million by 2026 according to a new study published by Polaris Market Research.

Global constrained layer damping market is expected to grow significantly over the forecast period from 2018 to 2026 owing to numerous advancements that is driven by a strong growth in various application industries such as automotive, aerospace, defense and construction. Their ability to subdue noise and vibrations generating between the connection of metal or plastic parts is expected to boost the market for constrained layer damping during the forecast period from 2018 – 2026. Constrained layer damping are forms of shear-related energy dissipation systems accomplished by interlocking two or more physical materials using a relatively thin viscoelastic layer. Some of the benefits of using constrained layer dampening systems for dealing with damping of noise and vibrations are the capability to attain high loss factors with comparatively thin configurations and that the rigidity of the composite system is not evidently increased. The systematic technological development of constrained layer damping is expected to be witnessed throughout the forecast period from 2018 – 2026.


The market for constrained layer damping is segmented on the basis of type into active and passive constrained layer damping. Passive constrained layer damping (PCLD) is a recognized technique to add damping to a system. PCLD is a facade damping treatment that consists of more than one viscoelastic layer and one or more non-actuated coerced layer. These PCLD systems are installed to the base layer, the layer that presents the unwanted resonance or vibration. However passive constrained layer damping systems has been replaced by active constrained layer damping (ACLD). This technology can be described as a failsafe, smart and efficient noise and vibration attenuation technology over a large frequency band. The market is also further segmented by viscoelastic material which includes butyl, vinyl, polyurethane and others. On the other hand, the constrained layer damping is additionally segmented into product type into aluminum, steel, non-metallic and others. The steel product type is expected to account for a lion share in the market owing to its application various industries. Steel along with composites have a superior damping capability to reduce structure-borne noise. Furthermore, on the basis of end-use industry the constrained layer damping market into automotive, aerospace, marine, electronics, construction and others. According to Polaris Market Research analysis, automotive end-use industry is expected to dominate the constrained layer damping market.


The future prospect of constrained layer damping looks promising due to the factors such as rising vehicle production coupled with advancing technologies for attaining NVH levels in the automotive industry is expected to drive the market over the forecast period. Additionally, trends in the construction industry to isolate noise and vibrations from structure is expected to fuel the market.

Asia Pacific was the largest regional market in 2017 and it is expected to retain its position during the forecast period. The region is anticipated to account for the maximum share of the overall worldwide market in terms of constrained layer damping systems. China being the largest production hub of automotive vehicle around the world is the major reason for the region’s stellar performance as the automotive industry holds the prime market share in the constrained layer damping market. Additionally, countries such as Japan, South Korea and India is further adding up to the growth of the total market.

Some of leading industry participants include Trelleborg AB, Nitto Denko Corporation, Pyrotek Inc., Sika AG, American Acoustical Products, Megasorber Pty Ltd, Vibratec, Autoneum, Henkel Ltd., Flexcon Company, Inc, Rousch, Avery Dennison Corporation, Heathcote Industrial Plastics, Soundown Corporation, Vibracoustic Gmbh, Polymer Technology Inc., and 3M among others.


Contact us
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , , ,
Subscribe to: Comments (Atom)